PRESS RELEASE 20th September, 2010 OUR CHILDREN BETRAYED ONCE AGAIN MINISTER FOR HEALTH AND HSE PUTTING YOUNG GIRLS AT RISK “Mothers Alliance Ireland, has made numerous attempts over the past number of years to stop the UNNECESSARY Mass Vaccination of our school-children, but, sadly, those with authority to stop this form of child abuse have […]
57,000 Pupils Finally Getting Cervical Cancer Jab
By: Eilish O’Regan, Health Correspondent, Irish Independent 13 September 2010 THE official rollout of the cervical cancer vaccine to more than 57,000 schoolgirls begins this week and should be completed within a month. The vaccine, which was at the centre of controversy over a delay in funding last year, will be offered to all girls […]
CU Center Slated to Test Cervical Cancer Vaccine
Sentinel Reports The Aurora Sentinel 27September 2010 Researchers from the University of Colorado Cancer Center are set to start human trials for a new cervical cancer vaccine in coming months, according to officials from the college. According to Bob Garcea, a UCCC researcher and a professor at the University of Colorado’s Boulder campus, researchers could […]
Cervical Cancer Vaccine Developed at CU Cancer Center Ready for Trials
Denver Business News 22 September 2010 An experimental cervical cancer vaccine developed by researchers at the University of Colorado Cancer Center in Aurora is ready to begin testing in human clinical trials, the center announced. The vaccine is intended to be less expensive than others now available and therefore better suited for developing countries such […]
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
The Lancet, Volume 374, Issue 9686, Pages 301 – 314, 25 July 2009 Background The human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine was immunogenic, generally well tolerated, and effective against HPV-16 or HPV-18 infections, and associated precancerous lesions in an event-triggered interim analysis of the phase III randomised, double-blind, controlled PApilloma TRIal against Cancer In young Adults […]
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- 10
- Next Page »
